A coverslip-based technique for evaluating Staphylococcus aureus biofilm formation on human plasma

Area of Science:

• Microbiology
• Infectious Diseases
• Biomaterials Science

Background:

• Staphylococcus aureus biofilm formation is crucial for chronic infections.
• Current in vitro assays (microtiter plates, flow cells) have limitations in mimicking in vivo conditions.
• Medical device-associated infections are often linked to host factor-coated surfaces facilitating bacterial attachment.

Purpose of the Study:

• To develop an improved in vitro biofilm assay that better replicates the in vivo environment.
• To integrate the benefits of existing microtiter plate and flow cell assays.
• To provide a platform for studying Staphylococcus aureus virulence factors and treatment efficacy.

Main Methods:

• Developed a novel in vitro biofilm assay using UV-sterilized coverslips coated with human plasma.
• Utilized confocal microscopy for biofilm visualization on the biotic surface.
• Validated the assay with clinical Staphylococcus aureus isolates and known biofilm mutants.

Main Results:

• The human plasma-coated coverslip assay provides a more physiologically relevant substratum for Staphylococcus aureus biofilm formation.
• The assay allows for robust biofilm development and visualization, similar to flow cell assays.
• The method successfully accommodated clinical isolates and mutants, confirming its utility.

Conclusions:

• This new biofilm assay effectively merges the advantages of microtiter plate and flow cell methods.
• It serves as a valuable tool for investigating Staphylococcus aureus virulence factors in biofilm formation.
• The assay can be used to evaluate the effectiveness of anti-biofilm treatment strategies.